Your search returned 15 results.

Results
	1.	Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studies. [electronic resource] by Elliesen, Jörg Trummer, Dietmar Producer: 20160826 In: International journal of women's health vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. [electronic resource] by Klipping, Christine Duijkers, Ingrid Trummer, Dietmar Marr, Joachim Producer: 20080922 In: Contraception vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Efficacy, safety and tolerability of the CCR1 antagonist BAY 86-5047 for the treatment of endometriosis-associated pelvic pain: a randomized controlled trial. [electronic resource] by Trummer, Dietmar Walzer, Anja Groettrup-Wolfers, Esther Schmitz, Heinz Producer: 20170815 In: Acta obstetricia et gynecologica Scandinavica vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study. [electronic resource] by Junge, Wolfgang Heger-Mahn, Doris Trummer, Dietmar Merz, Martin Producer: 20140428 In: Drugs in R&D vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study. [electronic resource] by Jensen, Jeffrey T Garie, Sona Grossova Trummer, Dietmar Elliesen, Jörg Producer: 20130103 In: Contraception vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. [electronic resource] by Hernádi, László Marr, Joachim Trummer, Dietmar De Leo, Vincenzo Petraglia, Felice Producer: 20090915 In: Contraception vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. [electronic resource] by Bart, Stephan Marr, Joachim Diefenbach, Konstanze Trummer, Dietmar Sampson-Landers, Carole Producer: 20120406 In: Contraception vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study. [electronic resource] by Endrikat, Jan Parke, Susanne Trummer, Dietmar Serrani, Marco Duijkers, Ingrid Klipping, Christine Producer: 20130617 In: Contraception vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies. [electronic resource] by Endrikat, Jan Parke, Susanne Trummer, Dietmar Schmidt, Werner Duijkers, Ingrid Klipping, Christine Producer: 20090113 In: Contraception vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. [electronic resource] by Blode, Hartmut Klipping, Christine Richard, Frank Trummer, Dietmar Rohde, Beate Diefenbach, Konstanze Producer: 20120507 In: Contraception vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. [electronic resource] by Klipping, Christine Duijkers, Ingrid Fortier, Michel P Marr, Joachim Trummer, Dietmar Elliesen, Jörg Producer: 20150324 In: The journal of family planning and reproductive health care vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study. [electronic resource] by Klipping, Christine Duijkers, Ingrid Fortier, Michel P Marr, Joachim Trummer, Dietmar Elliesen, Jörg Producer: 20150324 In: The journal of family planning and reproductive health care vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. [electronic resource] by Diefenbach, Konstanze Trummer, Dietmar Ebert, Frank Lissy, Michael Koch, Manuela Rohde, Beate Blode, Hartmut Producer: 20130424 In: International journal of women's health vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. [electronic resource] by Wiesinger, Herbert Eydeler, Urte Richard, Frank Trummer, Dietmar Blode, Hartmut Rohde, Beate Diefenbach, Konstanze Producer: 20130103 In: Clinical drug investigation vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). [electronic resource] by Bitzer, Johannes Banal-Silao, Maria Jesusa Ahrendt, Hans-Joachim Restrepo, Jaime Hardtke, Marion Wissinger-Graefenhahn, Ulrike Trummer, Dietmar Producer: 20150609 In: International journal of women's health vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)